Clinical Trial Update: Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating adding dexmedetomidine to morphine for refractory pain in metastatic cancer; study status completed across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pain

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Morphine (morphine)

Snippet

Sponsor: Hotel Dieu de France Hospital | Conditions: Refractory Pain, Metastatic Cancer | Phase 2, Phase 3 | Status: COMPLETED